On The Forefront – What You Need To Deliver Biomarker Data
Source: LabConnect
Systems established for traditional pharmacokinetic (PK) and pharmacodynamic (PD) analyses were not designed to support complex clinical trials of new drugs in development. The incorporation of biomarkers into early drug trials has challenged leading companies to reprioritize innovation and drive quality sample management systems. As clinical development pipelines expand, companies should explore partnerships that will allow for scalability, enabling efficient and improved sample management.
Webinar Agenda
Highlighting the importance of quality sample management in the development of immunotherapies
- Bridging the gap between research and clinical operations teams to design custom sample management processes
- Emphasizing the significance of real-time sample tracking to deliver high quality data
- Exploring new innovations and partnerships to enable efficient and improved sample management
- Reducing development timelines to bring effective immunotherapy to patients
VIEW THE WEBINAR!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Clinical Leader? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
LabConnect
This website uses cookies to ensure you get the best experience on our website. Learn more